Public-private partnership to rapidly strengthen and scale COVID-19 response in Western Kenya.

COVID-19 developing country digital dashboard epidemic preparedness public-private partnership

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 21 01 2022
accepted: 19 12 2022
entrez: 3 2 2023
pubmed: 4 2 2023
medline: 7 2 2023
Statut: epublish

Résumé

In Africa almost half of healthcare services are delivered through private sector providers. These are often underused in national public health responses. To support and accelerate the public sector's COVID-19 response, we facilitated recruitment of additional private sector capacity by initiating a public-private partnership (PPP) in Kisumu County, Kenya. In this manuscript we demonstrate this PPP's performance. COVID-19 diagnostic testing formed the basis for a PPP between Kenyan Medical Research Institute (KEMRI), Department of Health Kisumu County, PharmAccess Foundation, and local faith-based and private healthcare facilities: COVID-Dx. First phase COVID-Dx was implemented from June 01, 2020, to March 31, 2021 in Kisumu County, Kenya. Trained laboratory technologists in participating healthcare facilities collected nasopharyngeal and oropharyngeal samples from patients meeting the Kenyan MoH COVID-19 case definition. Healthcare workers in participating facilities collected patient clinical data using a digitized MoH COVID-19 Case Identification Form. We shared aggregated results from these data via (semi-) live dashboards with all relevant stakeholders through their mobile phones and tablets. Statistical analyses were performed using Stata 16 to inform project processes. Nine private facilities participated in the project. A patient trajectory was developed from case identification to result reporting, all steps supported by a semi-real time digital dashboard. A total of 4,324 PCR tests for SARS-CoV-2 were added to the public response, identifying 425 positives, accounting for 16% of all COVID-19 tests performed in the County over the given time-period. Geo-mapped and time-tagged information on incident cases was depicted on Google maps through PowerBI-dashboards and fed back to policymakers for informed rapid decision making. Preferential COVID-19 testing was performed on health workers at risk, with 1,009 tests performed (up to 43% of all County health workforce). We demonstrate feasibility of rapidly increasing the public health sector COVID-19 response through coordinated private sector efforts in an African setting. Our PPP intervention in Kisumu, Kenya was based on a joint testing strategy and demonstrated that semi-real time digitalization of patient trajectories can gain significant efficiencies, linking public and private healthcare efforts, increasing transparency, support better quality health services and informing policy makers to target interventions.

Identifiants

pubmed: 36733283
doi: 10.3389/fpubh.2022.837215
pmc: PMC9887331
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

837215

Informations de copyright

Copyright © 2023 van Duijn, Barsosio, Omollo, Milimo, Akoth, Aroka, de Sanctis, K'Oloo, June, Houben, Wilming, Otieno, Kariuki, Onsongo, Odhiambo, Ganda and Rinke de Wit.

Déclaration de conflit d'intérêts

SD, TS, CW, TR, EM, RA, and NH are employed by PharmAccess Foundation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

BMC Public Health. 2016 Sep 13;16:963
pubmed: 27618964
Global Health. 2016 May 26;12(1):23
pubmed: 27229322
Trop Med Health. 2020 Jun 17;48:48
pubmed: 32550822
PLoS Med. 2012;9(6):e1001244
pubmed: 22723748
JMA J. 2021 Jul 15;4(3):198-206
pubmed: 34414313
Glob Public Health. 2020 Jul;15(7):1083-1089
pubmed: 32352911
MMWR Morb Mortal Wkly Rep. 2020 Oct 02;69(39):1404-1409
pubmed: 33001872
Lancet. 2021 Apr 3;397(10281):1265-1275
pubmed: 33773118
Int J Tuberc Lung Dis. 2008 Nov;12(11):1274-8
pubmed: 18926037
Jt Comm J Qual Patient Saf. 2016 Aug;42(8):350-71
pubmed: 27456416
Int J Health Policy Manag. 2021 Dec 01;10(12):934-945
pubmed: 33619927
Int J Environ Res Public Health. 2022 Apr 07;19(8):
pubmed: 35457314
Health Aff (Millwood). 2009 Nov-Dec;28(6):1799-806
pubmed: 19887421
Vaccines (Basel). 2021 Aug 23;9(8):
pubmed: 34452061
Lancet. 2018 Jul 28;392(10144):261-262
pubmed: 30032979
BMJ Glob Health. 2021 Dec;6(12):
pubmed: 34853031
Lancet. 2006 Aug 5;368(9534):547-50
pubmed: 16890844
BMJ Open. 2022 May 19;12(5):e049949
pubmed: 35589368
Diagn Microbiol Infect Dis. 2022 Feb;102(2):115591
pubmed: 34920265
Int J Health Plann Manage. 2021 Nov;36(6):2035-2043
pubmed: 34350637
BMC Public Health. 2019 Nov 1;19(1):1438
pubmed: 31675935
J Med Virol. 2020 Nov;92(11):2465-2472
pubmed: 32525568
Front Public Health. 2019 Jan 08;6:374
pubmed: 30671427

Auteurs

Shannen van Duijn (S)

PharmAccess Foundation, Amsterdam Office, Amsterdam, Netherlands.

Hellen C Barsosio (HC)

Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya.

Mevis Omollo (M)

Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya.

Emmanuel Milimo (E)

PharmAccess Foundation Kenya Office, Kisumu, Kenya.

Isdorah Akoth (I)

Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya.

Robert Aroka (R)

PharmAccess Foundation Kenya Office, Kisumu, Kenya.

Teresa de Sanctis (T)

PharmAccess Foundation, Amsterdam Office, Amsterdam, Netherlands.

Alloys K'Oloo (A)

Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya.

Micah J June (MJ)

Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya.

Nathalie Houben (N)

PharmAccess Foundation Kenya Office, Kisumu, Kenya.

Charlotte Wilming (C)

PharmAccess Foundation, Amsterdam Office, Amsterdam, Netherlands.

Kephas Otieno (K)

Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya.

Simon Kariuki (S)

Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya.

Simon Onsongo (S)

Aga Khan Hospital Kisumu, Kisumu, Kenya.

Albert Odhiambo (A)

Department of Health, Kisumu County Government, Kisumu, Kenya.

Gregory Ganda (G)

Department of Health, Kisumu County Government, Kisumu, Kenya.

Tobias F Rinke de Wit (TF)

PharmAccess Foundation, Amsterdam Office, Amsterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH